Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06669949 · ClinicalTrials.gov registry record
Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
A clinical trial of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT06669949 is a study of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06669949, a study of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective longitudinal natural history study with a retrospective cross-sectional arm aimed at determining the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS), a recently recognized inborn error of metabolism. The central hypothesis is that age of onset, other disease features, and disease biomarkers will be predictive of quality of life (QOL) and survival in SPLIS patients.
Conditions Studied
Interventions
- OTHER no intervention
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2025-04-22 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06669949
The ClinicalTrials.gov registry entry for NCT06669949 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.
NCT06669949 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06669949 about?
NCT06669949 is a clinical study titled "Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)". This is a prospective longitudinal natural history study with a retrospective cross-sectional arm aimed at determining the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS), a recently recognized inborn error of metabolism. The central hypothesis is that age of onset, oth...
What is the current status of trial NCT06669949?
This trial is currently recruiting. The enrollment target is 28 participants. The study started on 2025-04-22. Estimated completion is 2030-12-31.
What conditions does trial NCT06669949 study?
This clinical trial studies the following conditions: Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS).
What interventions are being tested in trial NCT06669949?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT06669949?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06669949 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.